H2020COFUND2016–2021

NanoMedPhD · Nanomedicine Doctoral Programme

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2016-09-15 → 2021-09-14
EU contribution
€627,840
Participants
1
Scheme
MSCA-COFUND

Lines connect the coordinator with its partners.

Results in brief

Nanomedicine Doctoral Programme

Biomedical research is one of the most important factors of economic development in modern societies, and a strategic element of major importance for the economic growth of the European Union. Most specifically, nanomedicine is a field that is expected to produce great advances in the diagnosis and treatment of diseases based on the use of nanomaterials that have fundamentally different properties from classical materials, and this discipline is also expected to play a major role in facilitating personalized medicine, one of the most important healthcare objectives of the 21st century. On the other hand, it is known that the talent people working in research is the headstone of any Science and Technology System. In this context, NanoMedPhD has been designed as a new strategic programme to provide trans-national mobility for 8 Early-Stage researchers and offer them academic and research training that lead to the award of a doctoral degree in the emerging field of nanomedicine in three scientific areas: Nanodiagnostics, Therapeutic Nanosystems and Regenerative Nanomedicine. The research activity (thesis projects) are being developed in the Centre BIONAND, which is the first specialized centre in Spain (Malaga) focused exclusively towards healthcare-applied nanotechnology research with the aim of creating a world-class centre of excellence. BIONAND´s research lines are focused in the most important clinical challenges considered for nanomedicine in Horizon 2020, such as inflammation, neurodegenerative diseases, cardiovascular and cancer. In addition to this research training, the institution responsible for the academic formation is the University of Malaga through its Doctoral Programmes. In summary, the main objectives of NanoMedPhD are: - To increase the quality of research training at doctoral level in the emerging field of nanomedicine, focusing in research areas that lead to solve citizens’ health problems through new systems for diagnosis, prevention and treatment of diseases. - To develop and broaden research competences of Early-Stage researchers, through international, intersectoral and interdisciplinary research training. - To promote attractive research careers.

Data: CORDIS, © European Union

Project objective

Biomedical research is one of the most important factors of economic development in modern societies, and a strategic element of major importance for the economic growth of the European Union. In particular, according to the White Paper to the Horizon 2020 Framework Programme for Research and Innovation of the Nanomedicine European Technology Platform, nanomedicine underspins a strong research and emerging industrial healthcare sector in Europe. Based on excellent academic research and innovative SMEs, nanomedicine will actively contribute to the three pillars of the Framework Programme Horizon 2020. It is known that the talent of people working in research is the headstone of any Science and Technology System. In this framework, Bionand has designed the Nanomedicine Doctoral Programme (NanoMed PhD), a new strategic programme to provide trans-national mobility for early stage researchers and offer them training activities that lead to the award of a doctoral degree in the emerging field of nanomedicine. The academic supervision will take place through tutors from the PhD programs of University of Málaga, and the scientific supervision of the research activity will take place in Bionand through its Principal Investigators. Bionand is the first national centre in Spain devoted to research in nanotechnology applied to health. Regarding the academic formation, the fellows will be enrolled in one of the four Doctoral Programmes related to this discipline, offered by the University of Málaga (UMA), which is the academic partner of this proposal. NanoMed PhD will last for a period up to 60 months and will launch an open call for fellowships for a total number of 8 incoming fellowships, aiming at hosting and tutorizing early-stage researchers within BIONAND in order to obtain a doctoral degree, since one of the main objectives as benchmark centre in nanomedicine, is to develope and support the research in this field throughout the Autonomous Region of Andalusia.. Researchers applying for NanoMed PhD incoming grants will be included into experienced research groups where they will be able to start a research career in one of the most emerging discipline.

Original text from CORDIS.

Participants

  • FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P. · SevillaCoordinatorSpain

Links

Data: CORDIS, © European Union